CompletedNCT02558907MoCAUpdated Apr 4, 2017

Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology

An observational study in Geriatrics and Cancer, sponsored by Centre Francois Baclesse. Completed at 2 sites in France. Open to participants aged 71 Years and older. Per ClinicalTrials.gov, last updated 2017-04-04.

Sponsored by Centre Francois Baclesse · Observational

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 66
Ages: 71 Years and older
Sex: All

Study summary

Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric

Conditions studied

Geriatrics
Cancer

Keywords

geriatrics
cancer
MMS test
MoCA test
cognitive evaluation

In context

Lead sponsor

Centre Francois Baclesse is the lead sponsor of 109 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 71 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Probability sample

Study population

aged patients with 1st line treatment of their cancer will be received an examination oncogériatric

Inclusion criteria

Patient old over 70 years
Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned
Patient candidate an oncogeriatric assessment
Patient agreeing to participate in the study
French language
Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder
Patient having a life expectancy ≥ 6 months

Exclusion criteria

Exclusion Criteria:

Primitive cancer of the central nervous system or brain metastasis
Patients unable to meet the cognitive tests
Refusal to participate
Realization of a MMSE or MoCA test in the last 6 months

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 66 participants (actual)
Patient registry: No

Interventions

Othercognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests

What researchers measure

Primary outcomes

proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment
Time frame: before their first treatment for the cancer, at inclusion

Study locations

2 sites

CHU
Caen, 14033, France
Centre François Baclesse
Caen, France

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Apr 4, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT02558907
Lead sponsor: Centre Francois Baclesse
Responsible party: Sponsor
First posted: Sep 24, 2015
Start date: Sep 2015
Primary completion: Mar 2017
Completion: Mar 2017
Last update: Apr 4, 2017

Study contacts

Heidi LAVIEC, MD

principal investigator · Centre François Baclesse - CAEN

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centre Francois Baclesse

Start the discussion